Key trends shaping Middle East & North Africa employee benefits in 2025
What’s driving claims and how can multinationals respond?

The rapidly evolving nature of the employee benefits (EB) landscape in the Middle East and North Africa (MENA) region presents both challenges and opportunities for multinationals planning their EB strategies. Our latest claims data reveals health trends in this vast, diverse region – such as rising rates of chronic diseases and mental health issues – that employers need to address in order to plan effective EB programmes.
In this month’s Viewpoint, we look at the regional trends, with a special focus on the Gulf, where experts are highlighting growing employee demand for wellbeing benefits.
As we settle into 2025, these are the key trends emerging in the MENA region that multinational employers should be aware of...
Key MENA medical claims trends

All MAXIS’ MENA region data referenced in this article, covers Egypt, Jordan, Lebanon and the Gulf. It compares paid claims data from 2020 to 2023 to the pre-pandemic years of 2017-2019.1
Looking at the data in key markets in the MENA region, we’ve seen some interesting stories emerge.
We’ve seen a 186% growth in paid claim amounts for nervous system diseases (inflammatory and degenerative conditions and damage to the brain, spinal cord, or peripheral nervous system).2
According to The Lancet, neurological conditions in this region have been increasing more rapidly than the global average, led by stroke, migraine and dementia diagnoses. Parkinson’s disease, Alzheimer's disease and other types of dementia are also rising significantly across the MENA region. The Lancet linked this trend to ageing populations as life expectancy increases and recommends systemic change and lifestyle intervention to mitigate the problem.3
Neoplasm claims in the MENA region have also surged (by 143%). A neoplasm is an abnormal growth of tissue that can be benign (noncancerous) or malignant (cancerous).4 While some claims we record in the neoplasms category are for benign tumours, the most expensive treatments that make this category a top cost driver are for malignant cancer claims.
Cancer’s rise in the region mirrors a wider trend we see in our global data. We have seen a substantial rise in cancer-related claims costs worldwide (a 242% increase in 2023 compared to 2019). The number of claims being made has also grown (a 184% increase in incidence). With this rise in claims and costs, multinationals should be looking to take action to address cancer’s impact on their people.
Solutions for multinationals
Companies’ EB programmes can be used to respond to the multi-pronged challenge of rises in claims spending on cancers and nervous system diseases. Employers can look to enhance insurance coverage for their people. Where local insurers are limited, captive programmes can be used to tailor enhanced EB offerings to include comprehensive cancer care and screening for neurological and congenital diseases for employees and their families.
Focus on mental health
Mental health paid claim spending in the MENA region has also grown sharply (127%), according to our data. At the same time, we recorded growth in palpitations (over 35%) and cardiac signs and symptoms (nearly 45%). Mental health is generally underrepresented throughout our claims data, and a portion of cardiac signs and symptoms claims might be linked to stress and mental health issues.5
Given that private health insurance in many markets often offers limited or no coverage for mental health, we believe employees might be seeking treatment for the physical symptoms, rather than the underlying cause. This could then trigger a series of expensive diagnostic tests and investigations, leading to substantial costs.
What could be driving an increase in mental health claims in this region? The MENA region is currently experiencing an above global average medical trend rate (15.5%),6 high general inflation and currency volatility – all of which can contribute to economic anxiety. Research suggests financial concerns, coupled with long healthcare appointment waiting times, are also among leading worries for MENA employees.7
In recent years, we have observed slight increase in mental health claims in our data – and even documented the emergence of mental health claims for the first time in certain markets known for their traditionally reserved stance on such matters. This trend suggests a potential shift in attitudes towards mental health – which we can be seen as a positive development.
Solutions for multinationals
Mental health support is vital in any workplace, anywhere in the world. But for multinationals operating in regions where some employees may be personally affected by economic anxiety and geopolitical unrest, it is perhaps doubly important to ensure they have access to mental healthcare, via tools such as professional psychological support and counselling, and employee assistance programmes. And it’s also vital to ensure that employers champion a culture that encourages seeking support for mental health challenges, so that people know it’s ok to seek help.
Metabolic syndrome and diabetes:
A growing epidemic
Our 2024 whitepaper, How do industry, culture and gender affect employee health? Insights from MAXIS claims data, highlighted how the MENA region has a higher rate of endocrine, nutritional and metabolic disease costs than any other in our claims data.
One in four people in the Middle East are already affected by metabolic syndrome (a combination of medical disorders that together increase the risk of developing diabetes and cardiovascular disease).8 The prevalence of diabetes in this region is also projected to keep rising.
Spotlight on the Gulf
Why are rates of metabolic and endocrine diseases concentrated so highly in the MENA region? Focusing on the Gulf can shed some light on factors contributing to preventable disease such as type 2 diabetes. Its prevalence in the Gulf has been linked to obesity, physical inactivity (particularly among women and elderly people), rapidly urbanising environments, higher calorie diets linked to economic growth, increased life expectancy and genetic susceptibility.9
High rates of expat labour contribute to the rich diversity of the MENA region. But this migration trend is also important for multinationals to consider when they analyse why certain chronic health issues may be dominating their claims spending. In parts of the Middle East, such as the Gulf, a large South Asian expat workforce is one potential factor in diabetes claims trends. Diabetes is a leading disease in South Asian countries and expat communities.10
Solutions for multinationals
Multinationals active in the MENA region can help their people address their risk of metabolic syndrome and type 2 diabetes by ensuring their EB programme covers preventative screening programmes and supports healthy lifestyle education on issues such as smoking, diet and exercise. It’s also worth offering enhanced benefits such as fitness memberships and virtual wellbeing apps that cater to these needs. These trends suggest wellbeing solutions could be effective for Gulf employees – and not only as a preventive step to help reduce rates of chronic health issues like diabetes. These types of benefits could also help attract and retain talent.
Lilia Mokhtari from MetLife Gulf explained why demand is rising in the region for comprehensive coverage that extends beyond core medical insurance coverage.
Lilia said: “Everybody is expecting a proactive approach on people’s wellbeing and, in my view, this is the most-needed and demanded requirement after the balance of costs… the snapshot is that there is definitely a demand for comprehensive coverage, and at MetLife we’re quite advanced on this - especially when it comes to mental health, women’s health and inclusive benefits.”
Flexible working is in demand
Employee wellbeing is not only affected by benefits – workplace policies and company culture are clearly having an impact, too. While many employees have grown accustomed to hybrid and remote working models, there has been a recent push for a return to onsite working around the world. However, moves to call time on remote working may be unpopular among employees in Europe, Middle East and Africa, where statistics suggest desire for remote working roles remains high.

Solutions for multinationals
Employers in many parts of the world are considering how hybrid working patterns suit their business needs, and employers in the MENA region face the same question. They will need to balance onsite work policies with their objective of retaining talent as flexible working arrangements remain in demand.
Investing in your people in the MENA region
Alexandre Rizk, MAXIS Regional Inbound Executive responsible for the MENA region, says: “Multinationals operating in the MENA region want to meet employees’ needs and address rising claims costs, while still remaining competitive in this dynamic talent market. This is a challenge, but fortunately there are strategies available to them.
“As Lilia points out, inclusive wellbeing benefits are growing in popularity among talent in the MENA region – and this is a positive trend for employers looking to secure talent while also balancing rising costs.
“Enhancing your EB programme with benefits options that support your people to lead healthy lifestyles is not only helpful to support their physical and mental health – but also as a preventive step that could make an impact on chronic disease trends driving claims costs, such as diabetes.
“So, if you’re thinking about how to support your people working in the MENA region in 2025 and beyond, investing in your people via wellbeing initiatives is a strong strategy.”
[1] MAXIS GBN proprietary claims data, (2024)
[2] Anon. Upvio. ICD-10 Code for Nervous System Diseases: G00-G99 Comprehensive Guide https://upvio.com/blog/practice-management/icd-10-code-for-nervous-system-diseases-range-g00-g99 (Sourced: January 2025)
[3] GBD 2019 North Africa and the Middle East Neurology Collaborators (June 2024) The Lancet. Volume 12, Issue 6. The burden of neurological conditions in north Africa and the Middle East, 1990–2019: a systematic analysis of the Global Burden of Disease Study 2019 https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(24)00093-7/fulltext (Sourced: January 2025)
[4] Anon. Malignant neoplasm. Cleveland Clinic. https://my.clevelandclinic.org/health/diseases/22319-malignant-neoplasm (Sourced: January 2025)
[5] Anon. MAXIS GBN (2024) ‘How do industry, culture and gender affect your workforce’s health? Insights from MAXIS claims data' (Sourced: January 2025)
[6] Anon. Aon (2025) The Global Medical Trend Rates Report 2025 https://www.aon.com/en/insights/reports/the-global-medical-trend-rates-report (Sourced: January 2025)
[7] Anon. Willis Towers Watson (2024) 2024 Global Benefits Attitudes Survey https://www.wtwco.com/en-cz/insights/2024/09/understanding-the-employee-voice-the-2024-global-benefits-attitude-survey (Sourced: January 2025)
[8] Ahmed Sliem, H. Ahmed, S. et al (January-February 2012) Metabolic syndrome in the Middle East. Indian Journal of Endocrinology and Metabolism. 16(1) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3263199/ (Sourced: January 2025)
[9] Aljulifi, M.A. (May 2021), Saudi Medical journal. Issue 42, volume 5. Prevalence and reasons of increased type 2 diabetes in Gulf Cooperation Council Countries https://pmc.ncbi.nlm.nih.gov/articles/PMC9149705/ (Sourced: January 2025)
[10] Gujral, U.P., Pradeepa, R., et al. (April 2013) Type 2 diabetes in South Asians: similarities and differences with white Caucasian and other populations Annals of the New York Academy of Sciences. 1281(3) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3715105/ (Sourced: January 2025)
This document has been prepared by MAXIS GBN S.A.S and is for informational purposes only – it does not constitute advice. MAXIS GBN S.A.S has made every effort to ensure that the information contained in this document has been obtained from reliable sources but cannot guarantee accuracy or completeness. The information contained in this document may be subject to change at any time without notice. Any reliance you place on this information is therefore strictly at your own risk.
The MAXIS Global Benefits Network (“Network”) is a network of locally licensed MAXIS member insurance companies (“Members”) founded by AXA France Vie, Paris, France (“AXA”) and Metropolitan Life Insurance Company, New York, NY (“MLIC”). MAXIS GBN S.A.S, a Private Limited Company with a share capital of €4,650,000, registered with ORIAS under number 16000513, and with its registered office at 313, Terrasses de l’Arche – 92727 Nanterre Cedex, France, is an insurance and reinsurance intermediary that promotes the Network. MAXIS GBN S.A.S is jointly owned by affiliates of AXA and MLIC and does not issue policies or provide insurance; such activities are carried out by the Members. MAXIS GBN S.A.S operates in the UK through its UK establishment with its registered address at 1st Floor, The Monument Building, 11 Monument Street, London EC3R 8AF, Establishment Number BR018216 and in other European countries on a services basis. MAXIS GBN S.A.S operates in the U.S. through MAXIS Insurance Brokerage Services, Inc., with its registered office located in New York, USA, a New York licensed insurance broker. MLIC is the only Member licensed to transact insurance business in New York. The other Members are not licensed or authorised to do business in New York and the policies and contracts they issue have not been approved by the New York Superintendent of Financial Services, are not protected by the New York state guaranty fund, and are not subject to all of the laws of New York. MAR01552/0225
Like this piece? Read our other related articles
Life insurance: a traditional employee benefit we still need to talk about
Why death shouldn’t be a taboo topic in the workplace
The key employee benefits trends shaping 2025 and beyond
How will the EB landscape evolve in the New Year?
Financial wellness benefits for different life stages
Understanding employees' needs is key for an effective strategy